Literature DB >> 17615586

Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation.

Karsten Mahnke1, Sabine Ring, Theron S Johnson, Sonja Schallenberg, Kurt Schönfeld, Volker Storn, Tanja Bedke, Alexander H Enk.   

Abstract

Suppressive functions of CD4+CD25+ regulatory T cells (Treg) are mainly studied by their interaction with conventional T cells. However, there is evidence that Treg also interact with antigen-presenting cells (APC), leading to suppression of APC function in in vitro coculture systems. Studying the in vivo distribution of Treg after injection, we found that Treg are located in direct proximity to dendritic cells (DC) and affect their functional maturation status. After contact to Treg, DC up-regulate the inhibitory B7-H3 molecule and display reduced numbers of MHC-peptide complexes, leading to impaired T cell stimulatory function. When Treg-exposed DC were used to immunize animals against antigens, the DC failed to produce a robust immune response as compared to control DC. Thus, these data indicate that Treg are able to inhibit DC activation and produce an inhibitory phenotype of DC. Accordingly, Treg may recruit DC for the amplification of immunosuppression by restraining their maturation in vivo and inducing an immunosuppressive phenotype of DC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615586     DOI: 10.1002/eji.200636841

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.

Authors:  Paul L Crispen; Yuri Sheinin; Timothy J Roth; Christine M Lohse; Susan M Kuntz; Xavier Frigola; R Houston Thompson; Stephen A Boorjian; Haidong Dong; Bradley C Leibovich; Michael L Blute; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2008-08-11       Impact factor: 12.531

2.  Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy.

Authors:  Dongli Cai; Jiaming Li; Dingfeng Liu; Shanjuan Hong; Qin Qiao; Qinli Sun; Pingping Li; Nanan Lyu; Tiantian Sun; Shan Xie; Li Guo; Ling Ni; Liping Jin; Chen Dong
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

3.  FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells.

Authors:  Anita Schildknecht; Sabine Brauer; Corinne Brenner; Katharina Lahl; Hansjörg Schild; Tim Sparwasser; Hans Christian Probst; Maries van den Broek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

4.  Activation of the arylhydrocarbon receptor causes immunosuppression primarily by modulating dendritic cells.

Authors:  Anika Bruhs; Thomas Haarmann-Stemmann; Katrin Frauenstein; Jean Krutmann; Thomas Schwarz; Agatha Schwarz
Journal:  J Invest Dermatol       Date:  2014-09-24       Impact factor: 8.551

Review 5.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

6.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

Review 7.  B7-h3 and its role in antitumor immunity.

Authors:  Martin Loos; Dennis M Hedderich; Helmut Friess; Jörg Kleeff
Journal:  Clin Dev Immunol       Date:  2010-11-28

8.  Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.

Authors:  Vegard Tjomsland; Anna Spångeus; Per Sandström; Kurt Borch; Davorka Messmer; Marie Larsson
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

9.  Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.

Authors:  Feriel Hacini-Rachinel; Hanane Gheit; Jean-Benoit Le Luduec; Fariel Dif; Stéphane Nancey; Dominique Kaiserlian
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

10.  Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors.

Authors:  Tae Jung Jang
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.